Hearing Impairment, Strategies, and Outcomes in Emergency Departments
NCT ID: NCT03594500
Last Updated: 2025-11-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
133 participants
INTERVENTIONAL
2019-03-18
2020-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
NCT05028972
Hearing Resources and Outcomes in the Emergency Department (HERO-ED)
NCT03053531
Hearing Program in Primary Care
NCT05943509
fNIRs, Listening Effort, and Speech Intelligibility
NCT05330585
Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints
NCT07279441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention: PockeTalker
Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department
PockeTalker
The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED
Control: No PockeTalker
Consenting participants will be randomly assigned to the control group while receiving care in the emergency department
No PockeTalker
The control group will not receive PockeTalkers while they receive care in the ED
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PockeTalker
The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED
No PockeTalker
The control group will not receive PockeTalkers while they receive care in the ED
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Emergency severity index criterion of 4 or 5 (low acuity)
* Hearing Handicap Impairment Evaluation Screen greater than or equal to 24
* Capacity to consent to participate in research
Exclusion Criteria
* Emergency severity index criterion of 1-3 (high acuity)
* Hearing Handicap Impairment Evaluation Screen less than 24
* Inability to speak English or Spanish
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Chodosh, MD MSHS
Role: PRINCIPAL_INVESTIGATOR
VA NY Harbor Healthcare System, New York, NY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA NY Harbor Healthcare System, New York, NY
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HX002421-01
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IIR 17-068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.